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Glucose is catabolized in yeast via two fundamental
routes, glycolysis and the oxidative pentose phos-
phate pathway, which produces NADPH and the
essential nucleotide component ribose-5-phos-
phate. Here, we describe riboneogenesis, a thermo-
dynamically driven pathway that converts glycolytic
intermediates into ribose-5-phosphate without pro-
duction of NADPH. Riboneogenesis begins with
synthesis, by the combined action of transketolase
and aldolase, of the seven-carbon bisphosphory-
lated sugar sedoheptulose-1,7-bisphosphate. In the
pathway’s committed step, sedoheptulose bisphos-
phate is hydrolyzed to sedoheptulose-7-phosphate
by the enzyme sedoheptulose-1,7-bisphosphatase
(SHB17), whose activity we identified based on me-
tabolomic analysis of the corresponding knockout
strain. The crystal structure of Shb17 in complex
with sedoheptulose-1,7-bisphosphate reveals that
the substrate binds in the closed furan form in the
active site. Sedoheptulose-7-phosphate is ultimately
converted by known enzymes of the nonoxidative
pentose phosphate pathway to ribose-5-phosphate.
Flux through SHB17 increases when ribose demand
is high relative to demand for NADPH, including
during ribosome biogenesis in metabolically syn-
chronized yeast cells.INTRODUCTION
Eukaryotic cells consume glucose through two primary routes,
glycolysis and the oxidative pentose phosphate pathway.
Glycolysis produces ATP, NADH, and trioses for amino acids
and glycerolipid biosynthesis. The oxidative pentose phosphate
pathway generates NADPH, ribose for DNA and RNA synthesis,
and erythrose for amino acid biosynthesis. The rate and direction
of the glycolytic pathway are controlled by heavily regulatedenzymes that catalyze strongly thermodynamically favored reac-
tions, e.g., phosphofructokinase, fructose bisphosphatase, and
pyruvate kinase. Glucose enters the oxidative pentose phos-
phate pathway through the committed step glucose-6-phos-
phate dehydrogenase. Alternatively, glycolytic intermediates
can be converted into ribose by the enzymes in the nonoxidative
arm of the pathway. Unlike glycolysis and the oxidative pentose
phosphate pathway, the nonoxidative pentose phosphate
pathway is thought to be fully reversible, as it lacks any
committed (i.e., strongly thermodynamically driven) step.
The enzymatic steps in the nonoxidative pentose phosphate
pathwayarecontroversial.Thoughtextbookscontaina reasonable
sequence of mass-balanced steps catalyzed by known enzymes,
their ability to account for all isotopic distributions observed has
been debated (Berthon et al., 1993;McIntyre et al., 1989;Williams
et al., 1987). Moreover, regulation of the pathway flux, including
whether net flow is toward or away from ribose, remains poorly
understood. Inputs from other pathways or alternative reaction
sequences may be required to fully explain these discrepancies.
These issues are clearly important, as the growth of many tumor
cells requires upregulated activity of the nonoxidative pentose
phosphate pathway (Deberardinis et al., 2008).
Advances in mass spectrometry permit measurement of
metabolites more sensitively, specifically, and conveniently
than previously possible, allowing the revisitation of fundamental
questions regarding metabolic pathway architectures and regu-
lation (Fendt et al., 2010; Nakahigashi et al., 2009; Walther et al.,
2010). Untargeted methods, based on full scan mass spectrom-
etry, can detect both known and unexpected metabolites (Allen
et al., 2003; Saito et al., 2006). These untargeted methods have
been applied successfully in discovery metabolite profiling, an
approach that identifies the endogenous roles of enzymes by
searching for metabolites that accumulate upon enzyme inhibi-
tion (Saghatelian and Cravatt, 2005). This approach has revealed
that the endogenous substrates of enzymes are often not accu-
rately predicted by in vitro activity measurements (Saghatelian
et al., 2004).
In the best-characterized eukaryote S. cerevisiae, more
than 900 genes remain uncharacterized according to the
Saccharomyces Genome Database (SGD Project, 2010). Some
of these genes likely encode enzymes catalyzing metabolicCell 145, 969–980, June 10, 2011 ª2011 Elsevier Inc. 969
reactions, which potentially could be revealed by discovery
metabolite profiling. The availability of sequence, transcription,
and proteomic data facilitates prioritization of ubiquitously ex-
pressed, widely conserved candidate enzymes of unknown
function for metabolic analysis. In this study, we describe our
characterization of one such enzyme, SHB17, an abundant
budding yeast protein that links the pentose phosphate pathway
and glycolysis. Shb17 is a phosphatase that catalyzes the
specific dephosphorylation of the seven- and eight-carbon
sugars sedoheptulose-1,7-bisphosphate (SBP) and octulose-
1-8-bisphosphate (OBP). Shb17 catalyzes the committed
reaction of riboneogenesis, a sequence of reactions that leads
ultimately to ribose-5-phosphate production:
fructose-6-phosphate+glyceraldehyde-3-phosphate
4erythrose-4-phosphate + xylulose-5-phosphate
(1)
erythrose-4-phosphate+dihydroxyacetone phosphate
4sedoheptulose-1; 7-bisphosphate
(2)
sedoheptulose-1; 7-bisphosphate/sedoheptulose
-7-phosphate+Pi
(3)
sedoheptulose-7-phosphate+glyceraldehyde-3-phosphate
4xylulose-5-phosphate + ribose-5-phosphate
(4)
xylulose-5-phosphate44ribose-5-phosphate (5)
Shb17 flux (rxn 3) is altered by nutrient and growth demands. In
accordance with its role in feeding carbon to the pentose phos-
phate pathway, expression of SHB17 is coordinated with other
enzymes in the nonoxidative PPP, including transketolase
(TKL1 and TKL2, rxns 1 and 4) and ribose phosphate isomerase
(RKI1, rxn 5). These riboneogenic enzymes work in concert
during times of peak nucleotide demand to convert glycolytic
triose and hexose units to ribose. Riboneogenesis provides a
thermodynamically driven route of ribose production uncoupled
from formation of NADPH, allowing the cell to adjust the flux of
carbon to ribose in response to changing conditions.RESULTS
A Yeast shb17 Deletion Mutant Accumulates SBP
and OBP
We initiated a metabolomic screen of yeast deletion mutants of
genes of unknown function. Candidate genes encoding protein
domains similar to enzymes were identified by comparative
sequence analysis. Metabolomic phenotypes of mutant strains
were measured by reverse-phase ion pairing chromatography
coupled with high-resolution full-scan mass spectrometry (Lu
et al., 2010). We found that deletion of SHB17, formerly known
as the uncharacterized gene YKR043c, consistently led to the
accumulation of four metabolites and the depletion of a fifth
(Figure 1).970 Cell 145, 969–980, June 10, 2011 ª2011 Elsevier Inc.Candidate formulae were obtained based on exact masses
and included seven- or eight-carbon mono- or bisphosphory-
lated sugars. The formulae were verified by labeling cells with
15N and 13C (Hegeman et al., 2007) and observing no shift for
the nitrogen labeling and a shift of +7 or +8 daltons for the carbon
labeling (for the putative seven- and eight-carbon sugars respec-
tively). The presence of phosphate was verified based on mass
spectral fragmentation to [H2PO4]
. Collectively, the analytical
data revealed that the compounds observed were seven- and
eight-carbon mono- and bisphosphorylated metabolites. We
hypothesized that the accumulated compounds were sedohep-
tulose-1-phosphate (S1P), sedoheptulose-1,7-bisphosphate
(SBP), octulose-1-phosphate (O1P), and octulose-1,8-bisphos-
phate (OBP) and that the depleted compound was octulose-8-
phosphate (O8P) (Figure 1). Standards were synthesized for
S1P, SBP, and OBP, and retention time and fragmentation
patternsmatched to the accumulating endogenous compounds.
Although we did not synthesize O1P and O8P, the location of the
phosphate moiety was deduced by comparing fragmentation
patterns and retention times to those obtained with S1P and
S7P (Figure S1). Seven-carbon bisphosphorylated sugars were
known in the KEGG database, but not thought to exist in yeast.
Eight-carbon mono- and bisphosphorylated sugars were not in
metabolite databases but had been proposed in older literature
(Bartlett and Bucolo, 1968; Horecker et al., 1982; Paoletti
et al., 1979).
Shb17 Is a Selective Sedoheptulose and Octulose
Bisphosphatase
To determine which of the accumulated compounds was the
endogenous substrate for Shb17, we performed biochemical
assays incubating recombinant Shb17 protein with each of the
candidate substrates (S1P, SBP, and OBP). Incubation with
Shb17 led to depletion of SBP and OBP, but not S1P. S7P and
O8P accumulated as the products of reactions with SBP and
OBP, respectively. S7P is part of the nonoxidative pentose
phosphate pathway, which converts ribose-5-phosphate to the
glycolytic intermediates fructose-6-phosphate (F6P) and glycer-
aldehyde-3-phosphate (GAP). The sedoheptulose bisphospha-
tase activity of Shb17 is inhibited by vanadate (data not shown).
Phosphate transfer to AMP or ADP was not observed.
In addition to its observed activity as a sedoheptulose
bisphosphatase, Shb17 has previously been shown to exhibit
phosphatase activity against the structurally similar metabolite
fructose-1,6-bisphosphate (FBP) in vitro (Kuznetsova et al.,
2010). FBP does not accumulate in the shb17D strain
(log2[mutant/WT] = 0.048, p = 0.6). This suggests that SBPmight
be themore important in vivo substrate.Wemeasured the kinetic
parameters of purified Shb17 using both FBP and SBP as
substrates (Figure 2 and Figure S2). Shb17 preferentially hydro-
lyzes SBP, with a lower KM and higher vmax than observed using
FBP as a substrate (Table 1). Intracellular concentrations of
19 mM FBP and 0.19 mM SBP were determined by an isotope
ratio-based approach (Bennett et al., 2008). The velocity of the
enzyme acting on each substrate, assuming that the in vitro
measured parameters apply also in vivo, is given by Equation
(6) for the example of SBP as the substrate (Webb and Dixon,
1964):
A B
C D
Figure 1. Metabolomic Phenotype of shb17D
(A) Metabolite structures associated with metabolic phenotype of shb17D. For fragmentation data confirming compound structures, see Figure S1.
(B) Relative quantitation of metabolites. Data shown are arithmetic mean ± SE of n = 4 independent biological replicates.
(C) The negative ionization mode-extracted ion chromatogram for SBP in shb17D andwild-type S. cerevisiae. Inset: Mass spectrum displaying the accuratemass
for the parent ion (M) and natural 13C abundance ion (M+1) observed for SBP in negative ionization mode via LC/Exactive Orbitrap MS.
(D) Table of [M-H] ions with altered abundance between shb17D and wild-type.nSBP =
nSBP
KM ðSBPÞ
1+
½SBP
KM ðSBPÞ
+
½FBP
KM ðFBPÞ
(6)
Based on Equation (6), the estimated dephosphorylation rates
for SBP and FBP are similar. Using the observed concentration
of 11,500 molecules of Shb17 protein per cell (Ghaemmaghami
et al., 2003), we calculate that Shb17 dephosphorylates
300,000 molecules of SBP and 800,000 molecules of FBP
per cell per minute. At an average haploid cell volume of 42 fl
(Tyson et al., 1979), there are 5 million molecules of SBP and
500 million molecules of FBP per cell. Thus, Shb17 activity
substantially affects SBP, but not FBP, levels. Moreover, typicalflux through F6P is typically 10- to 20-fold greater than that
through S7P in glucose-grown yeast (Kleijn et al., 2005; Wang
and Hatzimanikatis, 2006). Thus, the relative contribution of
Shb17 to S7P production is greater than for F6P; this was
confirmed based on isotope labeling studies (see below). Thus,
though the intrinsic preference of Shb17 for SBP over FBP
(i.e., higher vmax/Km) is substantially offset by the higher cellular
concentration of FBP than SBP, the primary physiological role
of Shb17 appears to be the dephosphorylation of SBP and
perhaps also OBP.
Structure of Shb17-SBP Complex
Recently, Kuznetsova et al. (2010) determined the crystal struc-
ture of a catalytically inactivemutant of Shb17 (H13A) in complexCell 145, 969–980, June 10, 2011 ª2011 Elsevier Inc. 971
Figure 2. Hydrolysis of SBP and FBP by Purified Recombinant
Shb17: Dependence on Substrate Concentration
Data are the mean ± standard error for two independent experiments. Full data
for FBP are available in Figure S2.with FBP bound in the active site. FBPwas bound in an extended
linear form, unlike the thermodynamically preferred cyclic b-fura-
nose form observed in complexes with the gluconeogenic
enzyme fructose bisphosphatase (Brown et al., 2009; Koerner
et al., 1973). To examine the interaction of Shb17 with SBP, we
cocrystallized Shb17 (H13A) with SBP and solved the structure
of this complex at 2.2 A˚ resolution (Table S1 and Figure S3).
The structure revealed a protein dimer, as in the previous crystal
structures of Shb17 (Kuznetsova et al., 2010). Each monomer
contains a mixed a-b structure, with a central six-stranded
b sheet flanked by a helices on both sides. On one side of this
central b sheet is a substrate-binding site formed by the C
terminus of strand b1, the a1 helix and the b1-a1 and a1-a2 loops
(residues 14–29), and the a7, a8, and a9 helices and their inter-
vening loops (residues 101–139). Strand b7 (residues 228–234)
forms another boundary for the ligand-binding site and also
constitutes part of the dimer interface, hydrogen bonding with
the major b sheet of the interacting monomer. The ligand sedo-
heptulose 1,7-bisphosphate is best modeled in its b-furanose
form, which is the most common conformer of sedoheptulose
and its derivatives in solution (Kuchel et al., 1990).
The Shb17 structure revealed that SBP is bound in the active
site in a very similar manner to FBP (Figure 3A). This is possible
because SBP is bound in a furanose (cyclic) form, and therefore it
has almost the same length as FBP (the distances between the
P1 and P2 phosphorus atoms are 10.7 A˚ and 10.6 A˚, respec-
tively). The SBP molecule is coordinated by positively charged
residues on each end of the binding site that position the two
terminal phosphate groups. The C1 phosphate group (P1) thatTable 1. Kinetic Parameters of Shb17 with FBP and SBP as Substra
Substrate
KM vmax vmax/KM
mM mmoles/min mg protein l/min mg p
FBP 510 ± 50 2.6 ± 0.1 5.1 3 10
SBP 34 ± 8 7.8 ± 0.7 2.3 3 10
972 Cell 145, 969–980, June 10, 2011 ª2011 Elsevier Inc.is hydrolyzed by the enzyme is highly buried and held in position
by hydrogen bonds and salt bridges from the side chains of R12,
R69, and H176 (H13 would presumably also form a salt bridge in
the wild-type enzyme) (Figure 3B). The C7 phosphate (P2) is in
contact with the side chains of H178 and R181, and the side
chain of H244 from the second molecule in the asymmetric
unit hydrogen bonds to the C7 phosphate group. The phenyl
ring of Y24 lies underneath the ligand to form a platform for the
sugar molecule. In the b-furanose conformation, the C2 and C3
hydroxyl groups point into the protein and away from the solvent,
each forming two hydrogen bonds with the protein. The hydroxyl
group of Y102 contributes one hydrogen bond each to the C2
and C3 OH. In addition, the E99 carboxyl group and the T25
backbone amide hydrogen bond to the C2 and C3 hydroxyl
group, respectively. The C4 hydroxyl group points toward the
solvent and makes no direct hydrogen-bonding contacts with
the protein. In addition, the Shb17-SBP structure revealed the
presence of an additional density close to the side chains of
the conserved T16 and T25 (2.2 A˚ and 3.2 A˚) and to the P1
oxygen (2.9 A˚), which was interpreted as an Mg2+ cation (Fig-
ure 3B). This type of Mg2+ coordination is very similar to that
found in the regulatory and dynamin-like GTPases/ATPases,
where Mg2+ is not required for substrate hydrolysis but contrib-
utes to the phosphate coordination (Daumke et al., 2007; Rut-
thard et al., 2001; Zhang et al., 2000). There is a similar density
at this position in the structure of the Shb17 complex with
FBP, which was annotated as a water molecule (Figure 3C),
but potentially it might also represent a metal ion. Therefore,
although Shb17 and othermembers of the histidine phosphatase
superfamily are known to be metal-independent enzymes, it is
possible that some of them can useMg2+ for the cleavable phos-
phate coordination and charge neutralization.
Overall, the structures of Shb17 complexed with SBP or FBP
revealed similar positioning of the active site residues, suggest-
ing that both substrates are hydrolyzed using the same mecha-
nism. Compared to the structure of the Shb17-FBP complex,
however, Shb17 makes an additional interaction with SBP
between the C3-OH of SBP and the Y102 of the protein and
between the 1-phosphate and R12of the protein. These
hydrogen bonds, in addition to the more favorable sugar confor-
mation, presumably account for the increased affinity of Shb17
for SBP relative to FBP.
Sedoheptulose 1,7-Bisphosphate Is Synthesized
In Vivo by Fructose Bisphosphate Aldolase
There are two likely routes for in vivo synthesis of sedoheptulose
1,7-bisphosphate. The first involves formation of SBP by the
phosphorylation of S1P, which also accumulates in shb17D. The
second is via the aldol addition of dihydroxyacetone-phosphatetes
Intracellular
Concentration
Intracellular Concentration,
95% Confidence Interval
rotein mM mM
3 ± 5 3 104 19 19.9–20.5
1 ± 6 3 102 0.19 0.189–0.194
Figure 3. Structure of the Shb17/SBP Complex
(A) Overall fold of the Shb17 (H13A) in complex with SBP (PDB 3OI7, gray ribbon) shown in two orientations with secondary structural elements being labeled.
The SBP molecule (magenta carbon atoms) is shown in a stick representation.
(B) Close-up view of the active site of Shb17 in complex with SBP. The side chains of residues in contact with SBP are displayed in a stick representation
(green carbon atoms) and labeled. SBP is shown in a stick representation (magenta carbon atoms) and labeled, whereas theMg2+ ion is shown as a purple sphere
and labeled.
(C) Active site of Shb17 in complex with FBP, a similar view as (B). The red sphere denotes awatermolecule. Y102makes two hydrogen bondswith SBP, whereas
only one hydrogen bond can be formed between this residue and FBP. These hydrogen bonds are shown by dashed lines in (B) and (C).
See also Figure S3 and Table S1.(DHAP)anderythrose-4-phosphate (E4P) catalyzedby theubiqui-
tous glycolytic enzyme fructose bisphosphate aldolase. Similarly,
octulose-1,8-bisphosphate might be synthesized by phosphory-
lation of O1P or by the aldol addition of DHAP and ribose-5-
phosphate.
To explore these possibilities, we fed yeast a mixture of 70:30
[U-13C6]-glucose:unlabeled glucose. This mixture yields fully
labeled and unlabeled DHAP and E4P, as well as partially labeled
forms produced from scrambling reactions of the nonoxidative
PPP. From these heterogeneous pools, a labeled subunit may
react with an unlabeled subunit, giving rise to a partially labeledproduct (Szyperskia et al., 1996). In shb17D mutant cells, the
predominant partially labeled forms of SBP were 13C3 and
13C4, consistent with SBP being synthesized by aldolase-cata-
lyzed condensation of triose and tetrose subunits (Figure 4 and
Figure S4). Similarly, 13C3 and
13C5 were the predominant
partially labeled forms of OBP. The labeling patterns of S7P
and O8P were similar to those of SBP and OBP. Partially labeled
forms of S1P andO1P could not bemeasured due to poor signal-
to-noise ratio.
To examine the role of fructose bisphosphate aldolase (FBA) in
the in vivo synthesis of SBP and OBP, we decreased aldolaseCell 145, 969–980, June 10, 2011 ª2011 Elsevier Inc. 973
Figure 4. SBP and OBP Are Synthesized In Vivo by C3 + C4 and C3 + C5 Subunits via Fructose Bisphosphate Aldolase
(A) Cells were switched from unlabeled to 70:30 unlabeled glucose:[U-13C]-glucose. Labeling patterns of erythrose-4-phosphate (E4P), dihydroxyacetone-
phosphate (DHAP), ribose-5-phosphate (R5P), SBP, and OBP were measured in shb17D, where SBP and OBP accumulate and hence are more readily
quantitated. The reaction products sedoheptulose-7-phosphate (S7P) and octulose 8-phosphate (O8P) were measured in wild-type (for data on S7P in shb17D,
see Figure S4A). Labeling is reported 20 min after nutrient switch for all compounds except OBP, wherein data are taken at 120 min due to its slower labeling.
(B) Kinetics of labeling of SBP after switching shb17D cells with wild-type fructose bisphosphate aldolase (FBA1-wt) or the decreased abundance by mRNA
perturbation allele (FBA1-DAmP) into [U-13C6]-glucose. For associated pool size and kinetic data, see Figures S4B and S4C.
(C) Kinetics of labeling of SBP and S1P after switching shb17D cells into [U-13 C6]-glucose.activity, encoded by the essential gene FBA1, by lowering its
expression using a decreased abundance by mRNA perturba-
tion (DAmP) allele (Breslow et al., 2008). The flux of glucose
toward SBP andOBPwas thenmeasured by kinetic flux profiling
(Yuan et al., 2008). Cells were initially grown on unlabeled media
and then switched to fully isotope-labeled [U-13C6]-glucose.
Metabolism was quenched at various time points following the
switch, enabling us to monitor the rate at which isotopically
labeled carbon filled each metabolite pool. We applied this974 Cell 145, 969–980, June 10, 2011 ª2011 Elsevier Inc.method to four strains: wild-type, shb17D, FBA1-DAmP, and
a FBA1-DAmP/shb17D double mutant. Labeling of the direct
upstream intermediates of SBP, E4P, and DHAP was unaffected
by the FBA1-DAmP allele; however, labeling of SBP and OBP
was markedly slowed, verifying their cellular synthesis by
aldolase (Figure 4B).
Labeling dynamics provides an additional assessment of the
likelihood of SBP and OBP synthesis by aldolase versus by
S1P or O1P phosphorylation, which would require that the
isotopic labeling of S1P and O1P is faster than labeling of SBP
and OBP. Instead, S1P and O1P label more slowly than SBP
and OBP. This slow labeling of S1P or O1P is consistent with
their formation by hydrolysis of SBP and OBP, perhaps cata-
lyzed by an unidentified phosphatase.
Quantitation of Flux through SHB17 into the
Nonoxidative PPP
S7P can be produced either from SBP by Shb17 or through the
canonical pentose phosphate pathway (PPP). Flux from SBP to
S7P can be specifically measured based on the pseudo-
steady-state labeling patterns of SBP and S7P in cells fed
glucose singly labeled in its C6 position, [6-13C1]-glucose.
Shb17, but not the canonical PPP, produces [1,7-13C2]-S7P
from [6-13C1]-glucose (Figure 5A).
The metabolism of [6-13C1]-glucose through the PPP
produces only [7-13C1]-S7P. PPP flux in the oxidative direction
results in [6-13C1]-glucose-6P being decarboxylated at C1-
yielding [5-13C1]-pentose phosphates: ribulose-5P, ribose-5P,
and xylulose-5P (Xu5P). Transketolase then transfers the C1
and C2 carbons of xylulose-5P to ribose-5P, producing
[7-13C1]-S7P and [3-
13C1]-glyceraldehyde-3-phosphate (GAP).
Nonoxidative PPP flux from glycolytic intermediates toward
S7P produces the same labeling pattern. [6-13C1]-fructose-6P
combines with [3-13C1]-GAP via transketolase to produce
[5-13C1]- Xu5P and [4-
13C1]- erythrose-4P (E4P). [4-
13C1]- E4P
then reacts with another [6-13C1]-fructose 6P, producing via
transaldolase [7-13C1]-S7P.
When S7P is made via the Shb17 pathway, however, double
labeling from [6-13C1]-glucose can occur. The origin of this
double labeling is the aldolase-catalyzed condensation of
[3-13C1]-GAP with [4-
13C1]- E4P. This yields [1,7-
13C2]-SBP,
which is dephosphorylated by Shb17 to [1,7-13C2]-S7P. The
steady-state fraction of [13C2]-S7P relative to the fraction of
[13C2]-SBP equals the fraction of S7P produced through Shb17.
To determine flux through Shb17 by this approach, cells in
yeast nitrogen base were first grown on unlabeled glucose and
then switched to otherwise identical media with [6-13C1]-glucose
for 90 min, and the ratio of the doubly labeled fractions of S7P
and SBP was determined. The labeling duration was selected
to allow quasi-steady-state labeling of S7P and SBP while mini-
mizing carbon scrambling that can occur when the products of
Shb17 undergo further PPP reactions (e.g., formation of doubly
labeled pentoses from S7P via transketolase). To validate this
strategy, we compared shb17D mutants to wild-type yeast. In
wild-type, 5% of S7P was doubly labeled, whereas in shb17D
cells, there was < 1% doubly labeled S7P (Figure 5B). The 5%
13C2 labeling of S7P compared with 25% labeling of SBP implies
that 20% of S7P is synthesized by dephosphorylation of SBP by
Shb17 for wild-type yeast grown in minimal media. Conversely,
despite the 10% doubly labeled FBP measured in wild-type
yeast, no doubly labeled glucose-6-phosphate was observed,
implying that hydrolysis of FBP by Shb17 is not a significant
source of hexose phosphates.
Shb17 activity provides a strongly thermodynamically driven
route to S7P. Accordingly, we hypothesized that its function
might be to drive flux from dihydroxyacetone-phosphate and
erythrose-4-phosphate toward ribose-5-phosphate. Such fluxwould be useful when demand for ribose is not fully met by the
oxidative PPP, i.e., when demand for ribose exceeds that for
NADPH. In growing yeast, NADPH is consumed substantially
for amino acid, nucleic acid base, lipid, and sterol biosynthesis.
Accordingly, we hypothesized that providing exogenous amino
acids, nucleic acid bases, fatty acids, and sterols would increase
Shb17 flux. As shown in Figure 5B, such supplementation
increased flux through Shb17 from 20% in minimal medium up
to almost 50% in media containing the full set of additives.
A more overt way of increasing the requirement for Shb17
flux is genetic elimination of other routes of ribose production.
Deletion of glucose 6-phosphate dehydrogenase (ZWF1), the
enzyme that is responsible for the first committed step of the
oxidative PPP, caused 50% enhancement of Shb17 flux (Fig-
ure 5C). Deletion of the transaldolase genes TAL1 and NQM1,
which catalyze a portion of the nonoxidative pentose phosphate
pathway, quadrupled flux through Shb17 to S7P. The combina-
tion of zwf1D mutation with tal1D nqm1D mutations increased
flux over zwf1D alone. The overall flux through S7P is higher in
tal1D nqm1D than in zwf1D tal1D nqm1D, but zwf1 mutants
grow slowly in the methionine-supplemented minimal media
used in our flux experiments (data not shown). We anticipate
that this growth defect alters overall fluxes in the cell, which is
supported by prior evidence that zwf1 mutation reduces flux to
the nonoxidative pentose phosphate pathway (Zhao et al.,
2004; Jeppsson et al., 2002). Simultaneous deletion of ZWF1
and the transaldolase TAL1 yielded cells that depend on
SHB17 for efficient growth: the triple deletion zwf1D tal1D
shb17D grows slowly even on richmedium (Figure 5D). The three
single mutants, double mutants with binary combinations of the
mutations, or these single and double mutants in combination
with mutation of the TAL1 paralog NQM1 (Table S3) had no
significant effect on growth.
These results are consistent with three effective routes of
ribose production from glucose: the oxidative PPP (via Zwf1),
the canonical nonoxidative pentose phosphate pathway running
in reverse (via Tal1), or riboneogenesis (via Shb17). Both of the
latter two also require transketolase activity, which is itself
sufficient to make ribose by converting F6P and GAP to Xu5P
and E4P, with the disadvantage that Xu5P and E4P are made
in stoichiometric amounts even though cellular demand for
R5P exceeds that for E4P. This explains the viability but fitness
defect of the zwf1D tal1D shb17D triple-deletion mutant. Consis-
tent with the essential role for transketolase in converting S7P
formed by Shb17 into ribose, the zwf1D tkl1D tkl2D triple muta-
tion is lethal (Schaaff-Gerstenschla¨ger et al., 1993). Moreover, in
double mutants lacking all transketolase activity (tkl1D tkl2D),
there is no measurable flux through Shb17 (Figure 5C).
Shb17 Oscillates with Ribosomal Transcripts
in the Yeast Metabolic Cycle
Further evidence supporting the role of Shb17 as a riboneogenic
enzyme can be observed through analysis of periodic gene
expression during the yeast metabolic cycle (Tu et al., 2005). In
nutrient-limited yeast cultures, yeast cells can spontaneously
synchronize their metabolism and cell cycle so that the culture
alternates between respiration and fermentation. In gene ex-
pression data collected from these metabolically synchronizedCell 145, 969–980, June 10, 2011 ª2011 Elsevier Inc. 975
Figure 5. Shb17 Feeds Carbon into the Nonoxidative Pentose Phosphate Pathway
(A) Flux through Shb17 into S7P can be measured using [6-13C1]-glucose. [6-
13C1]-glucose leads to [7-
13C1]-S7P when S7P is made via the oxidative PPP or the
nonoxidative PPP. However, when S7P is produced from SBP via Shb17, a fraction of the S7P pool is doubly labeled: [1,7-13C2]-S7P. Flux is calculated based on
the measured isotopic distribution of SBP and S7P.
(B) Flux through Shb17 is increased by supplementation with nutrients whose endogenous production requires NADPH and thus drives oxidative PPP flux. All
measurements are performed in wild-type yeast. YNB is yeast nitrogen base without amino acids plus 2% glucose. Supplementation with amino acids includes
17 amino acids. Data shown are the arithmetic mean ± SE of n = 3 technical replicates.
(C) Effects of PPP gene deletions on Shb17 flux. The flux in the mutant strains differs significantly from wild-type as calculated by a t test (*p < 0.05, **p < 0.02,
***p < 0.001). Deletions are: glucose 6-phosphate dehydrogenase, zwf1D; transketolase, tkl1D/ tkl2D; and transaldolase, tal1D/nqm1D. Less than 1% doubly
labeled S7Pwas observed in any shb17D strain in all measured conditions. All strains were grown in YNB + 2%glucose and supplements as required: methionine
for zwf1D and synthetic complete media, including aromatic amino acids, for tkl1D/tkl2D.
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Figure 6. SHB17 Expression Cycles in Concert with the Yeast Metabolic Cycle
(A–D) A time series of gene expression during the 300 min yeast metabolic cycle is plotted from data presented in Tu et al. (2005), wherein each time interval
represents 25 min.
(A) SHB17 is coexpressed with ribosomal transcripts (shown here: two components of the 60S ribosomal subunit, RPL17B and RPL6B, and one of the 40S
subunit, RPS28B).
(B) Ribosomal protein transcript expression precedes transcripts associated with DNA replication (shown here: ribonucleotide reductase,RNR1, the B subunit of
DNA polymerase, POL12, and a DNA replication initiation factor, CDC45).
(C) SHB17 expression correlates with selected PPP transcripts, including transketolase (TKL1) and ribose 5-phosphate ketol-isomerase (RKI1).
(D) SHB17 expression is anticorrelated with other PPP transcripts, including transaldolase (TAL1) and glucose 6-phosphate dehydrogenase (ZWF1). y axis
displays log2 transformed intensity, with each gene median centered at 0.
(E) Riboneogenic pathway in yeast. The expression data in (A–D) suggest a coordinated role of the transketolase TKL1, the ribose ketoisomerase RKI1, and the
sedoheptulose bisphosphatase SHB17 in riboneogenesis. The aldolase FBA1 is constitutively expressed, consistent with its central role in both glycolysis and
gluconeogenesis. The ribulose epimeraseRPE1 is also continually expressed. Together, the enzymeswork to shunt glycolytic intermediates to ribose. The overall
scheme converts one hexose-P and three triose-P to three pentose-P units.cells, we observed that levels of the SHB17 transcript are corre-
latedwith expression levels of the ribosomal proteins (Figure 6A),
which are expressed prior to genes required for DNA synthesis
(Figure 6B) (Kudlicki et al., 2007). Thus, periodic SHB17 expres-
sion coincides with the peak demand for ribose phosphate that
occurs during ribosome biosynthesis.
Shb17 facilitates the conversion of glycolytic intermediates to
pentose phosphate units. Together with aldolase and transketo-
lase, it can convert one mole of F6P plus three moles of triose
phosphate to three moles of pentose phosphate. These reac-
tions define the previously undescribed pathway of riboneogen-
esis (Figure 6E). TKL1, the primary source of transketolase
activity (Schaaff-Gerstenschla¨ger et al., 1993), cycles concur-
rently with SHB17. The interconversion of the pentose phos-(D) Triple deletion of the sedoheptulose bisphosphatase SHB17, the glucose-6-p
defect. Optical density was measured during growth at 30C in YPD. Growth da
See also Table S2 and Table S4.phates Xu5P and R5P is achieved in two steps through the inter-
mediate ribulose-5P (Ru5P). In the first step, Xu5P is converted
to Ru5P via ribulose 5-phosphate epimerase (Rpe1). Ru5P is
then converted to R5P via ribose-5-phosphate ketol-isomerase
(Rki1). RKI1 expression oscillates during the metabolic cycle in
concert with TKL1 and SHB17, and expression levels of RPE1
are constant (Figure 6C).
Some of the transcripts of the PPP are anticorrelated with
SHB17 expression, including glucose 6-phosphate dehydroge-
nase (ZWF1), the first committed step of the oxidative branch
of the PPP (Figure 6D). The anticorrelation of SHB17 and TKL1
with ZWF1 expression suggests that riboneogenesis and the
oxidative branch of the PPP are active at distinct phases of the
yeast metabolic cycle.hosphate dehydrogenase ZWF1, and the transaldolase TAL1 causes a growth
ta are presented in Table S3.
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In the canonical nonoxidative PPP, transketolase and transal-
dolase are considered to convert twomoles of F6P and onemole
of triose phosphate to three moles of pentose phosphate.
However, TAL1 expression is anticorrelated with TKL1, SHB17,
and RKI1 across the yeast metabolic cycle (Figure 6D). Because
TAL1 and TKL1 are transcribed at different points in the yeast
metabolic cycle, Tal1 may not act in concert with Tkl1 for the
production of ribose-5-phosphate. Instead, Shb17, Tkl1, and
Rki1 presumably act in concert to produce ribose.
DISCUSSION
We report a previously unidentified enzymatic activity encoded
by SHB17 that hydrolyzes sedoheptulose-1,7-bisphosphate to
sedoheptulose-7-phosphate. In combination with transketolase,
ribulose-5-phosphate epimerase, and ribose-5-phosphate
isomerase, the activity of SHB17 provides a thermodynamically
driven pathway from trioses produced by glycolysis to the
synthesis of ribose. The flux through the Shb17 pathway is regu-
lated in response to biosynthetic and redox demands on the cell.
This alternative pathway may explain the observed increase in
S7P levels when oxidative pentose phosphate activity is in-
hibited, where previous models had predicted a decrease in
S7P (Ralser et al., 2007).
In a recent study, Kuznetsova et al. (2010) showed the ability
of Shb17 to hydrolyze the homologous substrate FBP and deter-
mined the crystal structure of Shb17 in complex with it. SHB17
deletion, however, does not alter the cellular levels of FBP,
whereas it elevates those of SBP.Motivated by thismetabolomic
data, we demonstrate that purified Shb17 exhibits higher activity
and affinity for SBP. The structure of the Shb17-SBP complex
reveals that this higher affinity results from binding of SBP in
the preferred b-furanose sugar conformation and from additional
hydrogen bonds between Shb17 and SBP. The current study
accordingly is an example of the power of combining metabolo-
mics with structural biology to assign enzyme function and
argues for similar integrated metabolomic-structural biology
analysis of other enzymes of unknown function.
Sedoheptulose and octulose bisphosphates are absent from
most reported pathways of microbial and animal metabolism,
but metabolomic analysis in multiple species reveals that these
compounds are not only present but abundant. In the distantly
related fission yeast S. pombe, we observe the formation of
doubly labeled S7P in cells fed [6-13C1]-glucose, suggesting
a similar flux from SBP to S7P (data not shown). In E. coli, trans-
aldolase mutants fed xylose employ transketolase to convert
xylose to S7P, which builds up to sufficient levels to result in
its phosphorylation by phosphofructokinase. The resulting SBP
is then cleaved by aldolase to generate E4P and DHAP (Nakahi-
gashi et al., 2009). Sedoheptulose and octulose compounds
have also been observed in human tissues (Bartlett and Bucolo,
1960; Bucolo and Bartlett, 1960). In macrophages stimulated
by endotoxin, a sedoheptulose kinase that produces S7P from
sedoheptulose must be downregulated for proper activation
(A. Haschemi, personal communication). Sedoheptulose-1,7-bi-
sphosphate is elevated in tumor material (Meijer and Elias, 1984)
and in oncogene-transformed cultured mouse cells (J. Fan and
J.D.R., unpublished data).978 Cell 145, 969–980, June 10, 2011 ª2011 Elsevier Inc.Previous description of SBP and OBP in mammalian metabo-
lism came from studies of an alternative form of the pentose
phosphate pathway from the canonical reaction sequence
shown in textbooks. The alternative pathway, known sometimes
as the L type (in contrast to the canonical F type), is purported to
be active in liver (Williams et al., 1987). Similar to the pathway
described here, the L-type PPP involves interconversion of
DHAP and E4P with SBP catalyzed by aldolase. The L-type
PPP, however, lacks sedoheptulose-1,7-bisphosphatase
activity. Instead, it relies on OBP-S7P phosphotransferase
activity, which has never been purified to homogeneity or cloned
genetically. Moreover, the net products and reactants of the
L-type pathway are identical to those of the canonical F type.
In contrast, in the pathway described here, there is net loss of
one high-energy phosphate bond, which serves to provide ther-
modynamic driving force for ribose formation. This, in turn,
conveys a physiological function, riboneogenesis.
The riboneogenic pathway has substantial similarity to the
Calvin cycle, the light-independent phase of photosynthesis
in which CO2 is condensed with ribulose-1,5,-bisphosphate. In
the Calvin cycle, as in riboneogenesis, sedoheptulose-1,7-bi-
sphosphate is formed when aldolase catalyzes condensation
of erythrose 4-phosphate and dihydroxyacetone phosphate.
Then, a sedoheptulose bisphosphatase dephosphorylates se-
doheptulose-1,7-bisphosphate to yield sedoheptulose-7-phos-
phate, which is converted to ribulose-1,5-bisphosphate, the
substrate for addition of carbon dioxide. The plant sedoheptu-
lose-bisphosphatases are members of the phosphoglycerate
mutase family distantly related to not only Shb17, but also the
fructose bisphosphatase Fbp1 and various phosphoglycerate
mutases. The plant enzymes are regulated by light and are local-
ized to the stroma of the chloroplast, where they participate in
carbon fixation. In contrast, Shb17 is localized to the cytoplasm
to coordinate glycolysis with the pentose phosphate pathway.
The demand for the products of the pentose phosphate
pathway varies depending on cell growth rate, redox stress,
and nutrient availability. It also varies during the cell cycle, as
ribose is ultimately the source of ribo- and deoxyribonucleotides.
Riboneogenesis allows cells to balance the demands of redox
homeostasis and biosynthesis.
EXPERIMENTAL PROCEDURES
Strains and Reagents
S. cerevisiae strains were derived from the synthetic genetic analysis (SGA)
deletion set (BY4743 background) (Tong et al., 2001) with the genotype
MATa ura3D0 leu2D0 his3D1 lys2D0 met15D0 can1D::LEU2+-MFA1pr-HIS3/
CAN1 ykr043cD::kanMX and a yar047cD::kanMX control in the same back-
ground. Prototrophic deletions were also created by homologous recombina-
tion using the YKR043CD::ClonNAT allele amplified by PCR from the above
deletion. Prototrophic controls were wild-type FY4 (Mat a) and FY5 (Mat a)
(Winston et al., 1995). Cells were grown in minimal media comprising 6.7 g/l
Difco Yeast Nitrogen Base without amino acids plus 2% (w/v) glucose. Addi-
tives were added in selected cases as described in the text and Extended
Experimental Procedures. Chemistry solvents and reagents were generally
the highest purity that is commercially available. Full details of sourcematerials
are available in the Extended Experimental Procedures.
Screening for Metabolic Phenotypes
Single colonies of yeast deletion and control strains (n = 4 of each) were grown
overnight to saturation at 30C in minimal medium. Cultures were set back to
OD6000.1 in 25mlmedia and allowed to grow at 30C tomidlog phase (OD600
between 0.4 to 0.6). Cells were harvested by vacuum filtering the cultures onto
47 mm diameter 0.45 mm nylon filters. Metabolism was quenched by quickly
placing the filter cell side down in 0.8 ml of 20C extraction solvent (40/40/
20 acetonitrile/methanol/water). The cells were allowed to sit in the extraction
solvent at 20C for 15 min, at which time cells were washed off of the filter
with an additional 200 ml solvent. The solvent-cell mixture was then centri-
fuged. The supernatant was removed and placed on ice. Pellets were resus-
pended in 200 ml fresh solvent, and a second extraction was performed for
15 min at 5C. The resulting mixture was then centrifuged, and the two super-
natants were combined. Aliquots were dried under N2(g) and resuspended in
HPLC-grade water prior to LC-MS analysis.
LC-MS Analysis
Full-scan LC-MS analysis, without the capability for MS/MS, was performed
on an ultrahigh-performance LC system coupled by negative ion mode elec-
trospray ionization to a standalone orbitrap mass spectrometer (Lu et al.,
2010). The LC method involves reversed phase ion-pairing chromatography
on a C18 column with tributylamine as the ion-pairing agent (Luo et al.,
2007). The mass spectrometer was run at 1 Hz scan speed with 100,000
resolving power. Metabolites differing between wild-type and knockout strains
were determined using MAVEN, an open-source LC-MS data analysis
package developed in house (Melamud et al., 2010). Instrumentation and
run parameters are described in detail in the Extended Experimental Proce-
dures. LC-MS/MS data was collected in selected cases on a hybrid ion
trap-orbitrap instrument.
General Synthesis of Mono and Diphosphosaccharides
A series of coupled enzymatic reactions were used to produce sedoheptulose-
1,7-bisphosphate (SBP), sedoheptulose-1-phosphate (S1P), and D-glycero-
D-altro-octulose-1,8-bisphosphate (OBP). In Reaction I, aldolase (4.1.2.13)
cleaves fructose-1,6-bisphosphate (FBP) into glyceraldehyde-3-phosphate
(GAP) and dihydroxyacetone-phosphate (DHAP). Reaction II uses aldolase
(4.1.2.13) to couple glyceraldehyde-3-phosphate to erythrose-4-phosphate,
erythrose, or ribose-5-phosphate to form the products SBP, S1P, or OBP,
respectively. In the case of SBP, erythrose-4-phosphate is derived from the
cleavage of fructose-6-phosphate by transketolase (2.2.1.1) in the presence
of GAP, which produces xylulose-5-phosphate as a side product. Finally,
triose phosphate isomerase (5.3.1.1) is used to facilitate conversion of DHAP
to GAP, thus driving the reaction and increasing yield. These methods are
modifications of previous work (Smyrniotis and Horecker, 1956; Valentin and
Bolte, 1993). For detailed syntheses, see Extended Experimental Procedures.
Protein Purification and Enzymatic Assays
Initial enzymatic screens for enzymatic activity were performed using in vitro
synthesized, untagged Shb17 (New England Biolabs Inc. PURExpress
In Vitro Protein Synthesis Kit). Subsequent studies were performed using
N-terminal His-tagged recombinant protein purified from E. coli. Reactions
were carried out at 30C at pH 7 and quenched using acetic acid. Reactants
and products in the quenched solutions were analyzed by LC-MS. For details,
see Extended Experimental Procedures.
Cell Growth Assays
Overnight cultures of the indicated mutant strains were diluted back to
OD600 nm 0.1 and grown for 4 hr. These cultures were diluted to OD600 nm
0.05, and growth was monitored by measuring optical density at 600 nM in
a BioTek plate reader incubated with shaking at 30C.
Crystallography
Crystals of SHB17(H13A) were grown at room temperature by hanging-drop
vapor diffusion. These crystals were soaked for 10 min in well solution plus
10 mM sedoheptulose-1,7-bisphosphate and then cryoprotected and flash
frozen. The structure of SHB17(H13A) with bound sedoheptulose-1,7-bi-
sphosphate was solved by molecular replacement from the protein coordi-
nates of SHB17(H13A) solved with fructose-1,6-bisphosphate (PDB code
3LL4). Additional details regarding structural determination methods aredescribed in Extended Experimental Procedures. Statistics for data collection
and structure refinement are summarized in Table S1.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
four figures, and four tables and can be found with this article online at
doi:10.1016/j.cell.2011.05.022.
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